Arrhythmogenic Right Ventricular Cardiomyopathy

N Engl J Med. 2017 Jan 5;376(1):61-72. doi: 10.1056/NEJMra1509267.

Authors

Domenico Corrado¹, Mark S Link¹, Hugh Calkins¹

Affiliation

¹ From the Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy (D.C.); the University of Texas Southwestern Medical Center, Dallas (M.S.L.); and Johns Hopkins Medical Institutions, Baltimore (H.C.).

PMID: 28052233
DOI: 10.1056/NEJMra1509267

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Arrhythmogenic Right Ventricular Dysplasia* / diagnostic imaging
Arrhythmogenic Right Ventricular Dysplasia* / genetics
Arrhythmogenic Right Ventricular Dysplasia* / pathology
Arrhythmogenic Right Ventricular Dysplasia* / therapy
Catheter Ablation*
Death, Sudden, Cardiac / prevention & control
Disease Progression
Electrocardiography
Humans
Mutation
Prognosis
Tachycardia, Ventricular / therapy

Substances

Adrenergic beta-Antagonists